INTRODUCTION
Proliferating human tissues harbor substantial populations of stem/progenitor cells carrying somatic mutations linked to neoplasia and other diseases Jaiswal et al., 2017) . This process is exemplified by the epidermis, which is exposed to UV light over decades and accumulates a high proportion of progenitors carrying UV-induced oncogenic mutations under strong evolutionary selection (Martincorena et al., 2015) . For example, 4%-14% of epidermal cells in sun-exposed human skin carry non-synonymous mutations of the tumor suppressor gene p53 (TP53) (Jonason et al., 1996; Martincorena et al., 2015) . Despite this, aging epidermis remains histologically and functionally normal, and, in comparison with the size of the mutant progenitor population, the incidence of keratinocyte cancers is exceedingly low. Here, we investigate the mechanisms that constrain p53 mutant progenitors and underpin the remarkable resilience of the epidermis to mutation.
The epidermis consists of layers of keratinocytes punctuated by hair follicles and sweat ducts . Keratinocytes are continually shed from the tissue surface and replaced by proliferation in the basal cell layer ( Figure 1A ). On commitment to terminal differentiation, proliferating basal cells exit the cell cycle and migrate into the suprabasal cell layers. They then undergo a sequence of changes in gene expression and cell morphology and are ultimately shed as anucleate cornified cells. Throughout life the epidermis self-renews, matching cell production in the basal layer with cell loss from the epidermal surface .
Various models of normal epidermal homeostasis have been proposed (Allen and Potten, 1974; Sada et al., 2016) . Multiple lineage tracing and intravital imaging studies suggest the interfollicular epidermis (IFE) is maintained by a single population of progenitor cells with stochastic fate (Clayton et al., 2007; Doupé et al., 2010; Lim et al., 2013; Rompolas et al., 2016; Roshan et al., 2016) . In this paradigm, progenitor cells divide to generate two progenitor daughters, two non-dividing differentiating cells or one cell of each type ( Figure 1B ). The outcome of individual progenitor cell divisions is unpredictable, but the probability of generating differentiated or proliferating cells is balanced. As a result, the average cell division generates one progenitor and one differentiating daughter cell across the progenitor population, achieving cellular homeostasis and ensuring the majority of clones with mutations that do not alter cell dynamics are lost by differentiation and subsequent shedding ( Figure 1B ) (Clayton et al., 2007) .
Epidermal progenitor fate is adaptable, enabling cells to both sustain normal cell turnover and respond to injury (Lim et al., 2013; Park et al., 2017; Roshan et al., 2016) . Following wounding, nearby progenitors produce more proliferating than differentiating daughters until the epidermis is repaired, after which they revert to normal, balanced behavior ( Figure 1C ). While the ability to modulate progenitor cell fate provides a robust mechanism of tissue repair, it also represents a potential vulnerability, as somatic mutations may drive progenitors to produce an excess of proliferating cells in the absence of injury . Unchecked, even a small bias toward proliferation may lead to clonal dominance and eventually tumor formation (Frede et al., 2016) .
Here, we focus on a p53 mutant detected in normal human epidermis, p53 R248W ( Figures 1D-1G , (https://cancer.sanger.ac. uk/cosmic/) (Martincorena et al., 2015) . This mutation is frequently found in human squamous cell carcinoma and has gain-of-function (GOF) properties, distinct from those of a p53-null allele (Muller and Vousden, 2014; Song et al., 2007) . p53 R248W is a contact mutant with altered DNA-binding properties and acts in dominant-negative manner over wild-type p53 when they are co-expressed (Song et al., 2007) . Several studies from cellular systems and humanized mouse models showed that p53 R248W plays a role in the cancer phenotype through increased proliferation, drug resistance, migration, and chromosomal instability (Song et al., 2007; Zhu et al., 2015) . However, recent studies suggest that some p53 mutants including p53 R248W exhibit GOF attributes only in cancer cells of particular lineages and the impact of the p53 R248W mutation on normal cell behavior is unclear (Sabapathy, 2015) . We hypothesized that p53 R248W may alter normal progenitor behavior to increase the likelihood of clonal persistence and the acquisition of additional mutations.
To test this hypothesis, we used a mouse model. Carcinogenesis in mouse skin has been studied extensively, and, like humans, mice may harbor mutated cells long term within normal epidermis (Berenblum and Shubik, 1949; Zhang et al., 2001 ). We developed a transgenic strain to track the fate of individual epidermal progenitor cells following induction of Trp53 R245W , the murine equivalent of human TP53
R248W
, in a background of wild-type cells, and the impact of physiological doses of UV light on mutant cell behavior.
RESULTS

Wild-Type Progenitor Behavior in Dorsal Epidermis
We began by characterizing the behavior of p53 wild-type (Clayton et al., 2007; Doupé et al., 2010; Klein et al., 2007) . To further explore the kinetics of keratinocyte turnover, we used a transgenic cell proliferation assay based on H2BGFP dilution over a period of up to 24 weeks (Figures S1B and S2I) (Doupé et al., 2012; Sada et al., 2016) . Keratinocytes showed a constant and homogeneous dilution pattern in a timescale of days. These data indicated that cycling keratinocytes divided at a similar rate (Figures S2K-S2M ; STAR Methods), arguing that growth arrest and senescence, two of the stress responses mediated by p53, are rare in wild-type IFE ( Figure S2J ) (Muller and Vousden, 2014) . Altogether, both lineage tracing and cell proliferation data were consistent with dorsal IFE being maintained by a single population of progenitors with balanced stochastic fate (Figures 1B and S3 ; STAR Methods). ). A conditional allele of p53*, with a GFP reporter linked to the C terminus of the p53* protein by a T2A self-cleaving peptide, was targeted to the p53 locus ( Figures  2A and S4 ) (Trichas et al., 2008 that the p53* protein had properties similar to those of the human p53
R248W
protein and observed perturbation of p53 targets and differentiation genes in cultured keratinocytes consistent with previous reports (Freije et al., 2014; Song et al., 2007; Truong et al., 2006) (Figures S4 and S5) . Following tag cleavage, a 20-amino-acid peptide remained at the C terminus of p53* protein. To test whether this peptide altered the properties of the p53* protein, we generated a second conditional mouse strain with an untagged p53 R245W mutant allele. RNA sequencing (RNA-seq) analysis of recombined primary cultures of p53* / * and the untagged p53 R245W/R245W keratinocytes revealed minimal differences in transcription ( Figure S5J ; Table S1 ). Figure 3E ). By 24 weeks, the p53 */wt clones had expanded so much that they had fused, but we noted a modest but statistically significant increase in the basal cell density (cells/area, p = 0.0007 by two-tailed Mann-Whitney test) ( Figures 3C, 3D , and 3F). We concluded that following induction p53 */wt cells are dominant over wild-type keratinocytes, leading to colonization of the IFE. Next, we investigated the cellular mechanism(s) that underpinned the competitive advantage of p53 */wt progenitors. Heightened resistance to the canonical p53 stress responses in the mutant cells seemed unlikely, as apoptosis was hardly detectable (0%-0.5%) and growth arrested/senescent wild-type keratinocytes were not detected in wild-type epidermis ( Figure S2J ; Table S2 ) (Clayton et al., 2007; Doupé et al., 2010) . The proportion of mutant and wild-type basal cells staining for 5-ethynyl-2 0 -deoxyuridine (EdU), a marker of the S phase of the cell cycle, was similar, arguing that the cell-cycle time and the proportion of progenitors were not substantially altered by the mutation (Figure 3G Figure 3D ).
Yet, EdU data at later time points suggest that this was not due to a decrease in the cell-division rate (Table S3 ). This argues that the cell-fate imbalance of mutant progenitors is not cell autonomous but responds to changes in the cellular environment, such as the observed increase in basal cell density by 24 weeks ( Figure 3F ) (Miroshnikova et al., 2018; Roshan et al., 2016) . Also, since the proportion of mutant cells adjacent to wild-type cells will decrease as the area of mutant epidermis rises, any imbalance in fate driven by competition between mutant and wild-type will inevitably decline over time. The lack of long-term clonal level data precluded further analysis to resolve between these mechanisms. However, it is clear that the reversion of p53 */wt cell dynamics toward normal contributed to the ability of normal tissue to tolerate mutant cells. 
Rosa26
Confetti/wt mice carrying a conditional multicolor ''Confetti'' allele targeted to the Rosa26 locus ( Figure 4D ) (Snippert et al., 2010) . Imaging of clones expressing both red fluorescent protein and GFPs revealed p53 */wt cells were indeed capable of terminal differentiation into cornified layer cells (Figures 4D and 4E) . Defects in keratinocyte differentiation may have a major impact on epidermal function and promote carcinogenesis, motivating us to examine the behavior of differentiating mutant cells more closely (Darido et al., 2016) . Over the first 6 months after induction, the area occupied by GFP-expressing mutant suprabasal cells rose even faster than the area occupied by mutant basal cells, arguing differentiating mutant cells accumulate in the tissue compared with their wild-type counterparts (Figures 4F and 3D) . In keeping with this hypothesis, the thickness of the IFE and the density of cells in the first suprabasal layer increased substantially associated with changes in cell morphology, signs of cellular disorganization and extra cell layer(s) .
In order to explore possible mechanisms that could lead to this scenario, we implemented computational simulations of the cellpopulation dynamics and tissue structure under various hypotheses incorporating parameters measured from the epidermis (STAR Methods). Briefly, we considered changes in either the proportion of symmetric divisions, stratification rate, or shedding rate along with the extent of cell-fate imbalance. Predicted changes in the proportion of p53 */wt cells in basal/suprabasal layers and tissue thickness were compared against experimental observations. Only p53 */wt progenitor cell-fate imbalance accompanied by a substantial reduction in the shedding rate was able to reproduce the patterns seen, arguing this was the most likely explanation ( Figure S6D ; STAR Methods). Strikingly, however, beyond 6 months, the area occupied by mutant suprabasal cells remained approximately constant while epidermal thickness decreased, arguing that mutant cell differentiation and shedding had been at least partially restored. This slow adaptation of mutant differentiating cell dynamics resulted in the preservation of tissue integrity without the development of epidermal tumors (Table S4) .
The mismatch between the proportion of mutant basal and suprabasal cells has implications for cell movement within the epidermis. In normal IFE, the majority of differentiating cells stratify vertically through the suprabasal cell layers ( Figure 5A ) (Doupé et al., 2010; Rompolas et al., 2016 Figure S1 -S6 and Tables S2 and S7 . (legend continued on next page) ( Figure 5A ). We hypothesized that there may be alterations in cell-cell adhesion permissive of lateral migration in mutant IFE. Transmission electron microscopy of p53 */wt IFE at a year post induction revealed widespread disruption of desmosomes (Fig- ures 5B and 5C) (Dusek and Attardi, 2011) . Expression of the desmosomal proteins, DSG3 and CDH1, and levels of membrane-associated CTNNB1, which binds CDH1, were diminished in p53 */wt compared with adjacent wild-type areas ( Figure 5D ). Despite these changes, the p53 */wt epidermis retained its ''outside-in'' barrier function ( Figures 5E and 5F ). We concluded that the lateral migration of p53 */wt suprabasal cells may be facilitated by the disruption of desmosomes.
Low-Dose UV Light Exposure Drives Mutant Clone Expansion
Human epidermis is frequently exposed to low doses of UV light, below the level that causes keratinocyte apoptosis and sunburn (Jonason et al., 1996) . As well as generating new mutations, repeated low doses of UV have been argued to drive the expansion of clones carrying p53 protein stabilizing mutations . We therefore investigated the effect of such physiological exposure.
First, we examined the impact of a short course of a low level UV-B (sub minimal erythema dose, MED, wavelengths 280-315 nm) treatment on p53 wt/wt and p53 */wt progenitors in vivo. The UV dose was titrated to induce detectable DNA damage with minimal change in apoptosis (Figures S7A and S7B; Table S5 ). An area of shaved dorsal epidermis was exposed to daily doses of UV for 4 days per week. After 2 weeks, cre was induced and samples collected from irradiated and adjacent unexposed epidermis for up to 6 weeks ( Figures 6A and 6B ). In wild-type p53, R-YFP mice, the proportion of EdU + basal cells and the mean number of cells per clone were increased in irradiated compared to unexposed epidermis, consistent with UV treatment accelerating the rate of cell division (Figures 6C, S7C, and S7D). However, the area of labeled epidermis remained approximately constant despite the increased rate of epidermal turnover ( Figure 6E ). We concluded that the progenitor population continued to maintain the epidermis with balanced production of progenitor and differentiating keratinocytes during low-dose UV irradiation. In induced p53* /wt animals, UV treatment greatly accelerated IFE colonization by mutant cells (Figures 6B and 6F) . However, the proportion of proliferating EdU + p53* /wt basal cells in irradiated IFE was similar to that in irradiated wild-type cells ( Figures  6C and 6D) . As in the unexposed epidermis, these observations indicate the fate of p53* /wt progenitors is biased toward proliferation. Accelerated turnover along with a fate imbalance is predicted to lead to a faster p53* /wt colonization ( Figure 6G ; STAR Methods). In humans, low-dose UV exposure continues over decades and results in a dense patchwork of epidermal clones carrying mutations in p53 and other genes (Martincorena et al., 2015) . To model this scenario, p53 */wt mice were induced and the skin given a single treatment with the mutagen dimethylbenzanthracene (DMBA) to load the epidermis with mutations (Abel et al., 2009) . Dorsal epidermis was then treated with sub MED UV for up to 9 months, and exposed and adjacent unexposed areas compared ( Figure 7A ). Over the first 12 weeks the area occupied by GFP-labeled p53* /wt cells expanded significantly faster in the presence of UV light, as shown above ( Figures 7B and 7C ). However, continuing exposure resulted in a progressive decline in the p53* /wt population ( Figures 7B-7D ). Given the short-term effect of UV treatment, the depletion of p53 */wt cells during long-term exposure was surprising. Several different scenarios can be envisaged to explain this observation. First, it might result from a non-cell-autonomous adaptation to a local tissue stress, e.g., such as sensitivity to increased cell density, which would also explain the restraining of p53 See also Figure S6 and clones. While no mutations were detected in epidermis exposed to UV for 12 weeks, we identified 58 mutations in epidermis exposed to UV for 36 weeks compared with 8 in adjacent unexposed skin in 7 mice (p = 0.02, 2-tailed Mann-Whitney test) (Figures 7G  and S7F ; Table S6 ). These mutant calls correspond with very large clones as the lower limit of detection was $0.15 mm 2 in area. The mutations were largely C > T nucleotide changes, consistent with the UV-light mutational signature, and the majority of mutations were non-synonymous, making it feasible for some of them to have altered cellular competitive fitness ( Figures  S7G and S7H ). We noted recurrent cancer-associated mutations in Trp53, finding R270C mutants in UV-exposed epidermis in 4/7 mice after 36 weeks UV. The mutations found in the non-induced samples show that the expansion of new mutations does not rely on hitch-hiking within p53 */wt clones. Taken together, these observations are consistent with clones carrying UV-or DMBAinduced mutations displacing p53 */wt cells during prolonged UV exposure. In contrast, in the adjacent unexposed areas of the skin, the expansion of the p53 */wt population was not impeded by competition (Figures 7B and 7C) .
A further prediction of the cell-competition hypothesis is that transgenic and UV-induced mutant clones must ultimately collide. One way to visualize such events is to immuno-stain for p53. This reveals cells carrying UV-induced, protein-stabilizing mutations, such as Trp53 R270C , but does not detect the low levels of wild-type p53 or mutations that do not stabilize the protein including p53* ( Figure S5H ) (Jonason et al., 1996) . We observed an increase in the areas covered by p53 immunopositive cells from 12 to 36 weeks under UV exposure but barely detected any in adjacent un-irradiated epidermis at 36 weeks ( Figures 7B and 7H) . In several cases, these cells were in direct contact with p53 */wt regions, infiltrating underneath differentiating edges of p53 */wt clones ( Figure 7H ). We concluded that cells carrying protein-stabilizing mutations in p53 do indeed collide with p53 */wt cells during prolonged UV exposure. Altogether, these results suggest that, in addition to the phenotypic adaptation observed in the non-irradiated experiments, competition between mutant clones may be an important factor in constraining p53 mutant clone expansion in the evolving mutational landscape of normal epidermis
DISCUSSION
Here, we show that the phenotype of epidermal progenitor cells carrying a heterozygous p53 gain-of-function mutation adapts to alterations in the cellular environment. In mice protected from UV light, p53* confers a strong competitive advantage over wild-type progenitor cells, as the average mutant cell division generates more dividing than differentiating progeny. In addition, retardation of terminal differentiation and shedding leads to mutant cell accumulation in the suprabasal layers. Unchecked, the combination of progenitor cell fate favoring proliferation and a decrease in cell shedding would be sufficient to generate tumors (Frede et al., 2016) . However, the progressive attenuation of the mutant phenotype enables the epidermis to retain its functional integrity despite a high burden of p53 mutant cells.
The mechanisms underpinning the adaptation of p53 */wt cells remain to be determined. The slowing of expansion of the p53 */wt basal cell population beyond 6 months post induction is accompanied by crowding of cells in the basal layer. A similar phenomenon has been observed in ''imprisoned'' UV-induced p53 mutant clones and Notch mutant keratinocytes Zhang et al., 2001 ). Keratinocyte differentiation is sensitive to mechanical forces suggesting that basal cell crowding may promote a return toward cellular homeostasis (Le et al., 2016; Roshan et al., 2016) . New technologies will be required to determine the possible role of feedback effects from suprabasal cell crowding on epidermal proliferation and tissue turnover. A persistent legacy of p53 */wt mutation is the loss of desmosomes and downregulation of expression of CDH1 and other adhesion proteins, consistent with the observation that the human p53 R248W mutant represses the expression of CDH1 in vitro (Dusek and Attardi, 2011; Wang et al., 2009 ). However, within the mixed population of mutant and wild-type cells the tissue does not exhibit a barrier or fragility defect.
In non-UV-exposed epidermis, the early competitive dominance of the p53 */wt mutant is explicable in terms of cell-autonomous effects on progenitors. The short-term effects of low- progenitors retain a bias in fate, generating more progenitor than differentiating daughters. See also Figure S7 and Tables S5 and S7. dose UV light exposure may also be explained within this paradigm. UV irradiation increases the rate of cell division of both wild-type and mutant progenitors, but the imbalance of cell fate in mutant cells remains. The result is a substantial acceleration of epidermal colonization by p53 */wt cells.
DMBA/UV exposure leads to a complex and heterogeneous mutational landscape. After long-term UV exposure, the p53 */wt population declines but is not entirely displaced. We hypothesize that individual clone fates would then depend on the chance acquisition of additional mutations and the competitive fitness of neighboring mutant clones. It remains to be seen whether competitive interactions promote, inhibit, or are neutral in carcinogenesis. Properties that allow a particular mutant to survive in early clonal competition could differ from those required for outgrowth of neoplastic cell population (Aktipis et al., 2013) . The stepwise acquisition of further mutations may then be key for breaking these evolutionary bottlenecks (Nowell, 1976) . This study argues that the patchwork of clones carrying oncogenic mutations in sun-exposed human epidermis is shaped by both phenotypic adaptation and cell competition. Understanding how mutant progenitor clones interact is key to understanding not only epidermal physiology, but also the formulation of rational approaches to prevent malignant transformation.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice strains and induction of allele All experiments were conducted according to UK government Home Office project licenses PPL22/2282 and PPL70/7543. Animals were maintained at specific and opportunistic pathogen free health status and were immune competent. No animals were involved in previous experiments and were drug naive prior to the start of experiments. Adult mice 12 weeks or more weeks in age were used for in vivo experiments. Animals were maintained on a C57/Bl6 genetic background, housed in individually ventilated cages and fed on standard chow. Both male and female animals were used for experiments. Trp53 flR245W-GFP/wt knock-in mice were generated by TaconicArtemis GMBH, Germany. In the targeting vector, exons 5 to 11 of the wild-type Trp53 gene were flanked by loxP sites and an additional transcriptional STOP cassette inserted between the Trp53 3 0 untranslated region (UTR) and the distal loxP site, in order to prevent transcriptional read through to downstream exons (Figure 2A) . A second Trp53 genomic region from exon 5 to exon 11, including the splice acceptor site of intron 4 was introduced 3 0 of the distal LoxP site. This duplicated region included a Trp53 R245W mutation introduced into exon 7 and a cassette including a glycine-serineglycine flexible linker, a self-cleaving T2A peptide and the eGFP coding sequences inserted into exon 11, between the last codon of Trp53 and the translation termination codon. Two positive selection markers were also introduced. A Neomycin resistance gene flanked by Frt sites was inserted 3 0 of the 5 0 LoxP site in exon 4, downstream of the predicted transcriptional initiation site. A Puromycin resistance gene flanked by F3 sites was placed downstream of the 3 0 UTR from the duplicated region. The targeting vector was generated using BAC clones from the C57BL/6J RPCIB-731 BAC library and was fully sequenced. After transfection into the C57BL/6N
Tac embryonic stem cell line, clones that had undergone homologous recombination were selected using puromycin and neomycin and screened by Southern blotting. The conditional Trp53 strain was generated by Flp-mediated deletion of the selection markers. Prior to cre-mediated recombination these animals (p53 */wt ) express TRP53 protein from two wild-type alleles. Once the wild-type Trp53 genomic region is deleted by cre both the Trp53 mutant carrying the R245W mutation and the eGFP reporter are transcribed.
For lineage tracing of control, Trp53 wild-type progenitors, the Rosa26 flYFP/wt (R-YFP) mice which express yellow fluorescent protein (YFP) from the constitutively active Rosa 26 locus were used (Srinivas et al., 2001 (Snippert et al., 2010) . Following induction this strain yields cells expressing one of 4 colors of reporter from the Rosa26 locus and the GFP reporter of p53 transcription. Cells doubly positive for red fluorescent protein and GFP were scored in experiments. Each reporter line was crossed onto the Ah creERT line in which transcription from a transgenic CYP1A1 (arylhydrocarbon receptor, Ah) promoter is normally tightly repressed (Kemp et al., 2004) . Following treatment with the non-genotoxic xenobiotic b-napthoflavone the Ah promoter is induced and a cre recombinase-mutant estrogen receptor fusion protein (creERT) is expressed. In the presence of tamoxifen, the cre ERT protein enters the nucleus to mediate recombination. For lineage tracing experiments, the relevant floxed reporter line was crossed onto the Ah creERT strain. Doubly transgenic male and female animals were induced by a single interaperitoneal (i.p) injection of 80 mg/kg b-napthoflavone and 1 mg tamoxifen at 11-16 weeks of age. GFP and YFP expressing clones were visualized by immunostaining with an anti-GFP antibody.
To estimate the rate of epidermal cell division a transgenic proliferation assay was used (Doupé et al., 2012) . Mice doubly transgenic for the reverse tetracycline-controlled transactivator (rtTA-M2) targeted to the Rosa26 locus and a HIST1H2BJ-EGFP fusion protein (HGFP) expressed from a tetracycline promoter element were treated with doxycycline (DOX, 2 mg ml -1 in drinking water sweetened with sucrose) for 4 weeks. DOX was then withdrawn and animals were culled at different time points to track HGFP dilution.
To determine the proportion of proliferating cells, 100 mg of 5-ethynyl-2 0 -deoxyuridine (EdU) (Life technologies) was injected intraperitoneally 1 h before culling animals.
Primary culture and in vitro induction of allele Primary mouse keratinocytes were isolated directly from tail epidermis of 4-12 week-old male and female C57/BL6 wild-type, p53 */wt , and p53 */* mice and cultured in Keratinocyte Serum Free media (KSFM, Life technologies) supplemented with 1mg/ml Epidermal growth factor, 45 mg/ml Bovine pituitary extract, 20 mM HEPES-NaOH pH7.2-7.5, 1% Penicillin-Streptomycin and CaCl 2 to give a final Ca 2+ concentration of 0.02 mM for growth media (GM) and 0.6 mM for differentiation media (DM). Cre-mediated recombination was carried out in vitro using an adenovirus carrying Cre recombinase (Adeno-cre, Vector Laboratories cat.no. 1045). When primary cultures reached 50%-60% confluency, cells were incubated with Adeno-cre at 2x10 6 pfu/ml in GM for 18 hours at 37 C. Virus was then removed by washing in Hank's Balanced Salt Solution (HBSS, Life technologies) three times. Cells maintained in GM for another 24 hours prior to use in experiments.
METHOD DETAILS Ultraviolet (UV) irradiation
A UV irradiator UV-2 from Tyler Research Corporation was used for this study. During irradiation, animals were placed in a custommade restrainer that restricted exposure to part of the dorsal skin. The dose of UVB-irradiation was titrated in wild-type C57BL/6 mice. A sub minimal erythema dose of UVB (750J/m 2 ) was determined from the appearance of the skin, Cyclobutane Pyrimidine staining and level of cleaved Caspase 3. Ahcre ERT -R-YFP and Ahcre ERT -p53 */wt mice were lightly shaved on the back with electric shaver 3 days prior to the start of irradiation course, then exposed to sub MED UVB daily, 4 times a week, and shaved once a week. The irradiance was monitored by dosimeter every day. For short term treatment, mice were induced with b-napthoflavone and tamoxifen after 2 weeks of irradiation and irradiation continued as before. Animals were culled at intervals as described in the text. UV-irradiation of cultured cells was performed with a UV irradiator (Uvitec, CL-508M with 5 3 8 W 312 nm tubes). Prior to UV-irradiation, cells were rinsed in HBSS briefly, exposed to a dose of 25 mJ/cm 2 UVB in HBSS and then placed in growth media.
Wholemount sample preparation
Whole back skin was lightly shaved and treated with hair removal cream (Nair Tough Hair, Coarse/Dark). The skin was then cut into rectangular pieces of approximately 4 by 5 mm and incubated in PBS containing 5mM EDTA at 37 C for 2 hours. Samples were transferred into PBS and the epidermis was carefully scraped off using curved scalpel while holding one corner of the skin with forceps. The epidermal wholemounts were fixed in 4% paraformaldehyde in PBS for 30 minutes and then stored in PBS at 4 C.
Immunofluorescence
For staining, wholemounts were blocked in staining buffer (0.5% Bovine Serum Albumin, 0.25% Fish Skin Gelatin, and 0.5% Triton X-100 in PBS with 10% goat or donkey serum according to the secondary antibody used) for 1 hour at room temperature. Samples were incubated with primary antibody in staining buffer overnight, washed in PBS containing 0.2% Tween-20 four times, incubated with fluorchrome-conjugated secondary antibody for 2 hours at room temperature and washed as before After the final wash, samples were incubated with 40,6-diamidino-2-phenylindole (DAPI, 1 mg ml -1 ) in PBS at least for 20 minutes and mounted on slides using Vectashield Mounting Medium with DAPI (Vector Labs). EdU incorporation was detected with a Click-iT imaging kit (Life technologies) according to manufacturer's instructions. Cryosections (20 mm thickness) were fixed in 4% paraformaldehyde in PBS for 10 minutes and stained as described above. All immunofluorescence images are representative of at least 3 animals.
Imaging
Confocal images were acquired on Leica TCS SP5 II or SP8 microscopes using 10x, 20x or 40x objectives. Typical settings for acquisition of z stacks were optimal pinhole, line average 4 scan speed 400 Hz and a resolution of 1024 3 1024 pixels or 2048 3 2048 pixels. Image analysis was performed using Volocity 6 or 6.3 image processing software (Perkin Elmer).
Transmission Electron Microscopy
Small pieces of skin (1 mm 3 ) were fixed at 20 C for 2 hours in 2% paraformaldehyde with 2.5% glutalaldehyde in 0.1 M sodium cacodylate buffer at pH 7.42 with 0.1% MgCl 2 and 0.05% CaCl 2 . They were then rinsed three times for 10 minutes each in sodium cacodylate buffer with chlorides and placed into 1% osmium tetroxide in sodium cacodylate buffer only, at room temperature for a further 2 hours, rinsed 3 times again, mordanted with 1% tannic acid for 30 minutes and rinsed with 1% sodium sulfate for 10 minutes. The samples were then dehydrated through an ethanol series and stained en bloc with 2% uranyl acetate for 1 hour at the 30% ethanol stage and embedded in Epon resin. Ultrathin transverse sections were cut on a Leica UC6 microtome and mounted onto grids before contrasting with uranyl acetate and lead citrate. Finally, images were recorded on an 120kV FEI Spirit Biotwin using an F4.15 Teitz CCD camera and measurements of the junction gaps made directly using Tecnai User Interface software.
Clonal imaging
After immunostaining wholemounts, clones were imaged by confocal microscopy and the number of basal and suprabasal cells in each clone counted in live acquisition mode.
Epidermal permeability barrier function Epidermal barrier function was assessed by Lucifer yellow (l ex 428 nm, l em 540 nm) dye diffusion assay. Mouse back skin was lightly shaved and small pieces were placed dermis side down on PBS-soaked Whatman filter paper. 10 mL of 1 mM Lucifer Yellow (Sigma L0259) in PBS was applied onto the surface of the skin and parafilm was laid on it to ensure the sample was covered with the solution. Following incubation at room temperature for 1 hour, samples were frozen in Tissue-Tek O.C.T compound (Sakura) and cyrosections (20 mm) were analyzed by confocal microscopy.
Immunoblotting Cells were lysed in buffer containing 20 mM HEPES NaOH pH7.2-7.5, Glycerol 10%, 0.4 M NaCl, NP-40 0.5% (Sigma), 0.2 mM EDTA, 1 mM Dithiothreitol (DTT), and 0.01% Halt Protease and Phosphatase inhibitor (ThermoFisher Scientific, cat.no.78415) and centrifuged at 13000 rpm at 4 C for 10 minutes. Protein concentrations were measured using standard Bradford protein assays (BioRAD QuickSTART Bradford Dye Reagents, cat.no.500-0202). Lysates were mixed with equal amount of 2x loading buffer (100mM Tris-HCl pH6.8, 4% SDS, 20% Glycerol, Bromophenol blue and 0.2% b-mercaptoethanol) and boiled at 96 C for 5 minutes. 4-10 mg of each sample was loaded onto a 10% or 12% of SDS-polyacrylamide gel. Proteins were separated by electrophoresis and transferred onto Immobilon-P membrane (pore size 0.45 mm, Millipore). Membranes were incubated in blocking buffer (5% dried skimmed milk, PBS, 0.1% Tween-20) at room temperature for 1 hour and then with primary antibodies diluted in blocking buffer for 1 hour at room temperature or overnight at 4 C on rocking platform. After washing in 0.1% Tween-20 PBS three times, HRP conjugated secondary antibodies (Dakocytomation) diluted in 0.5% skimmed milk in PBST were applied to the membrane for 30 min at room temperature on a rocking platform followed by three washes in 0.1% Tween-20 PBS 20 min each. Proteins were detected using Immobilon Western Chemiluminescent HRP substrate (Millipore WBLUC0500) or SuperSignal West Femto Chemiluminescent Substrate (Thermo Scientific, cat.no. 34095) for high sensitivity.
Mass Spectrometry
Sample preparation cDNAs encoding wild-type murine p53, p53 R245W and p53 R245W with a C-terminal cleaved T2A mutant sequence were amplified by PCR using cDNA from transgenic animals. A p53 S387A mutant was constructed by PCR mutagenesis. To produce retroviruses, pBabe puro IRES-EGFP plasmids carrying one of the above cDNAs were transfected into Amphotrophic phoenix producer cells (ATCC) using Lipofectamine 2000, according to manufacturer's instructions (ThermoFisher). Culture media containing retrovirus was treated with polybrene (final concentration 8 mg/ml) and used to infect primary p53 À/À mouse embryonic fibroblasts (MEFs) (Olive et al., 2004) . Whole cell lysate from the MEFs was prepared as described above, desalted using Amicon Ultra-0.5 Centrifugal Filter Unit with Ultracel-10 membrane and diluted with immunoprecipitation (IP) lysis/Wash buffer. Immunoprecipitation Approximately 4 mg of cell lysate was used for immunoprecipitation. CM5 p53 (Vector Labs Cat No #VP-P956) antibody was cross-linked with A/G magnetic beads using Pierce TM Crosslink Magnetic IP/Co-IP kit following the manufacturer's instructions (ThermoScientific Cat No #88805). The lysate was pre-cleared and applied to 150 ml of A/G magnetic beads cross-linked with the p53 antibody. The beads were then washed and the protein was eluted by boiling at 95 C for 5 min in non-reducing buffer (2 x concentration of 100 mM Tris-HCl pH 6.8 (Sigma SLBC0806V), 4% SDS, 20% Glycerol, Bromophenol blue (BDH prolabs 101184K). The total IP product was loaded on a 10% Tris-HCl acrylamide gel (Bio-Rad Cat No #161-155) and protein bands visualized with SimplyBlue CoomassieÒ G-250 stain following manufacturer's instructions (ThermoScientific Cat No #LC6060) . The band at appropriate size was cut out and digested into peptides for liquid chromatography tandem-mass spectrometry. Liquid Chromatography-Mass spectrometry/Mass spectrometry (LC-MS/MS) Experiments were performed using a nanoAcquity UPLC (Waters Corp., Milford, MA) system and an LTQ Orbitrap Velos hybrid ion trap mass spectrometer (Thermo Scientific, Waltham, MA). Separation of peptides was performed by reverse-phase chromatography using a Waters reverse-phase nano column (BEH C18, 75 mm i.d. x 250 mm, 1.7 mm particle size) at flow rate of 300 nL/min. Peptides were initially loaded onto a pre-column (Waters UPLC Trap Symmetry C18, 180 mm i.d x 20mm, 5 mm particle size) from the nanoAcquity sample manager with 0.1% formic acid for 3 minutes at a flow rate of 10 mL/min. After this period, the column valve was switched to allow the elution of peptides from the pre-column onto the analytical column. Solvent A was water + 0.1% formic acid and solvent B was acetonitrile + 0.1% formic acid. The linear gradient employed was 3%-40% B in 60 minutes.
The LC eluent was sprayed into the mass spectrometer by means of a standard Thermo Scientific nanospray source. All m/z values of eluting ions were measured in the Orbitrap Velos mass analyzer, set at a resolution of 30000. Data dependent scans (Top 10) were employed to automatically isolate and generate fragment ions by collision-induced dissociation in the linear ion trap, resulting in the generation of MS/MS spectra. Ions with charge states of 2+ and above were selected for fragmentation. Post-run, the data was processed using Protein Discoverer (version 2.1., ThermoFisher). Briefly, all MS/MS data were converted to mgf files and the files were then submitted to the Mascot search algorithm (Matrix Science, London UK) and searched against a Uniprot Mus musculus database. A fixed modification of carbamidomethyl (C) and variable modifications of oxidation (M) and deamidation (NQ) were selected. A peptide tolerance of 10 ppm (MS) and 0.6 Da (MS/MS) were also selected along with 2 missed cleavages.
Transcriptome analysis
Total RNA extraction from cultured primary mouse keratinocytes was carried out using the QIAGEN RNeasy Mini kit according to manufactures instructions (QIAGEN). cDNA was synthesized using the Quantitect Reverse Transcription kit following manufactures instructions (QIAGEN) and diluted 20-foled prior to qPCR analysis.
qRT-PCR was performed on StepOne Plus Real-Time PCR system (Life technologies). Each reaction (20ml) contained 5ml cDNA, 10 ml of TaqManÒ Universal PCR Master Mix (Life technologies) and 1 ml of an appropriate taqman probe. Following PCR parameters were used: hold 95 C for 10 min, followed by 45 cycles of step 1 at 94 C for 15 s, step 2 at 60 C for 55 s and acquiring to cycling A (FAM). All reactions were performed in triplicates. Data was analyzed using The StepOnePlus Real-Time PCR System and Excel.
For RNA-seq, libraries were prepared in an automated fashion using an Agilent Bravo robot with a KAPA Standard mRNA-Seq Kit (KAPA BIOSYSTEMS). In house adaptors were ligated to 100-300 bp fragments of dsDNA. All the samples were then subject to 10 PCR cycles using sanger_168 tag set of primers and paired-end sequencing was performed on Illumina's HiSeq 2500 with 75 bp Target gene TaqMan probe ID (Life technologies)
Lce3d Mm04337274_sH
Lor Mm01962650_s1
Mdm2 Mm01233136_m1
Cdkn1a Mm04205640_g1
Rprm Mm00469773_s1
Fas Mm01204974_m1
Dusp2 Mm00839675_g1
Tubb2b Mm00849948_g1
